Advertisement
Research Article| Volume 30, ISSUE 10, P1934, October 2008

Download started.

Ok

Dear Dr. Walson

      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Clinical Therapeutics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Lucasti C
        • Jasovich A
        • Umeh O
        • et al.
        Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: A phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
        Clin Ther. 2008; 30: 868-883
      1. Merrem (Meropenem) [package insert]. AstraZeneca, Wilmington, DE2007
        • Chastre J
        • Wunderink R
        • Prokocimer P
        • et al.
        Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: A multicenter, randomized study.
        Crit Care Med. 2008; 36: 1089-1096
        • Nicolau DP
        Pharmacodynamic optimization of β-lactams in the patient care setting.
        Crit Care. 2008; 12: S2